Impinj Inc (PI) Stock Price Today
Aura AI Summary
Key Stats
- $5.28BMarket Cap
- -Volume
- TechnologySector
- $241.9152W High
- $91.3452W Low
- -Typical Hold Time
- $5.41BEnterprise Value
- -Div Yield
- -Trading Activity
Track Impinj Inc (PI) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Impinj Inc has traded between a low of $91.34 and a high of $241.91, highlighting its annual price range. Buy and sell Impinj Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Impinj Inc
Impinj, Inc. is a leading provider of RAIN RFID (radio-frequency identification) solutions. The company's platform includes endpoints (tag chips), connectivity devices (readers and gateways), and software, enabling businesses to wirelessly identify, locate, and authenticate everyday items. Impinj's technology is crucial for applications in retail, supply chain management, healthcare, and logistics, helping businesses to automate inventory, track assets, and improve operational efficiency.
Most Recent News
Babcock & Wilcox rated STRONG BUY on growth from data center power solutions and major contracts.
Babcock & Wilcox (BW) is rated a strong buy due to its strategic position in providing fast, modular power solutions for data centers amid rising demand and grid limitations. The company secured a $2.4 billion Base Electron contract and has a $14 bil...
Great Western Mining starts drilling at Nevada's Defender Tungsten Project aiming for first resource estimate by 2026 end.
Great Western Mining Corporation has launched a fully funded drilling program at its Defender Tungsten Project in Nevada, targeting a maiden mineral resource estimate by the end of 2026. The program involves drilling at least 7,000 feet across up to ...
First commercial kidney transplant in Australia using Hansa's Idefirix treatment marks a key milestone.
Hansa Biopharma announced the first commercial living donor kidney transplant in Australia using Idefirix (imlifidase), a treatment that helps highly sensitized patients overcome immune barriers to transplantation. This milestone is significant as it...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.